terbutaline,Brethine, Bricanyl, and Brethaire are no longer available in the U.S.
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
GENERIC NAME: terbutaline
BRAND NAME: Brethine (No longer available in the U.S.), Bricanyl (No longer available in the U.S.), Brethaire (No longer availablein the U.S.)
DRUG CLASS AND MECHANISM: Terbutaline is a member of a class of drugs called beta adrenergic receptor agonists (stimulators) that is used for treating asthma and other diseases of the airways. Other drugs in the same class of drugs include albuterol (Proventil), metaproterenol (Alupent), pirbuterol (Maxair), and salmeterol (Serevent). Asthma is a breathing problem caused by narrowing of air passages (bronchial tubes) through which air moves in and out of the lungs. These airways can be narrowed due to the accumulation of mucus, spasm of the muscles that surround them (bronchospasm), or swelling of their linings due to the accumulation of fluid. Airway narrowing leads to shortness of breath, wheezing, and cough. Terbutaline is a bronchodilator, a medication that dilates (expands) air passages in the lungs. It attaches to beta adrenergic receptors on muscles surrounding the air passages, causing the muscles to relax and dilate the air passages. Wider air passages allow more air to flow in and out of the lungs. Increased airflow reduces shortness of breath, wheezing, and cough. Terbutaline also is used for delaying premature labor by relaxing the muscles of the uterus that are responsible for expelling the fetus at the time of delivery. The FDA approved terbutaline in 1974.
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets: 2.5 and 5 mg. Injection: 1 mg/ml. Inhaler: 0.2 mg/puff. Nubulizer: 1 mg/ml.
STORAGE: Tablets and injection should be stored at room temperature, 15-30 C (59-86 F).
DOSING: The recommended adult oral dose for treating bronchospasm due to asthma, emphysema, or bronchitis is 2.5-5 mg 3 to 4 times daily approximately 6 hours apart while awake. The maximum dosage is 15 mg/day.
The recommended subcutaneous (under skin) dose is 0.25 mg every 15-30 minutes for two doses. The maximum dose is 0.5 mg within 4 hours.
The recommended dose for the inhaler is 2 puffs every 4 to 6 hours.
The dose for preterm labor is 2.5 to 10 mcg/min by intravenous infusion initially, then increase amounts every 10 to 20 minutes. The typical effective dose is 17.5 to 30 mcg/min. Treatment should not exceed 72 hours.
DRUG INTERACTIONS: Combining terbutaline with thioridazine (Mellaril) may increase the occurrence of abnormal heart rhythms because both drugs can cause abnormal heart rhythms. The effects of terbutaline (a beta stimulant) are reversed by beta-blockers, for example, atenolol (Tenormin), nadolol (Corgard), propranolol (Inderal), and metoprolol (Lopressor). Conversely, terbutaline may reduce the effect of beta-blockers. Therefore, terbutaline and beta-blockers should not be used together.
PREGNANCY: Terbutaline reduces uterine contractions and may inhibit labor. There are no adequate studies of terbutaline in pregnant women.
NURSING MOTHERS: Terbutaline is found in small amounts in the breast milk of nursing women. The American Academy of Pediatrics considers terbutaline to be compatible with breastfeeding.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index